SAN DIEGO--Through an expanded licensing agreement, Aurora Biosciences will provide additional assay development and screening of a group of G-protein-coupled receptors isolated by Merck. Aurora will also develop instruments and implement software enhancements for Merck's high-throughput screening system platform to enable new assay plates to be used.
Merck Expands Genomics, Automated Instrumentation With Aurora Biosciences
Apr 20, 2000
Premium
Filed under
What's Popular?